Introduction to and update of "cost effectiveness in new technology in cervix cancer screening"

Max Robinowitz¹

• ¹Division of Clinical Laboratory Devices, Office of Device Evaluation, Center for Devices and Radiologic Health, Food and Drug Administration, Rockville, MD 20850, USA. myr@cdrh.fda.gov